2D-BioPAD aims to introduce a fast and cost-effective, non-invasive, reliable, digitally and graphene-enabled point-of-care in-vitro diagnostics system for supporting the early diagnosis and progression monitoring of Alzheimer's Disease directly at primary healthcare settings.
2D-BioPAD leverages the unique properties of 2D materials (2DM) to deliver a graphene-based PoC IVD system that will enhance biosensing; identify and quantify up to five AD biomarkers in blood samples; offer an easy to use and understand digital interface; and employ AI to improve the overall system implementation, and thus drive the next generation of graphene design and implementation.
The 2D-BioPAD project also contributes to a greener healthcare digital supply chain by introducing a low-power, advanced, digitalised PoC IVD system, able to cost-effectively support widely accessible early diagnosis and progression monitoring of AD in primary healthcare settings.
📖 Read more in our Annual Report 2023, which can be found on our website! Link in bio!
#biomedical #AI #medical #medicalapplication #graphene #materialscience #2dmaterials #tech #futuretech #researchanddevelopment #scientificresearch #alzheimers #healthcare #earlydiagnosis